IMMUNITY TARGETING COMMON CORE ANTIGENS OF GRAM-NEGATIVE BACTERIA

被引:31
|
作者
TYLER, JW
CULLOR, JS
SPIER, SJ
SMITH, BP
机构
[1] Departments of Clinical Pathology, School of Veterinary Medicine, University of California at Davis, Davis, California
[2] Departments of Medicine, School of Veterinary Medicine, University of California at Davis, Davis, California
关键词
D O I
10.1111/j.1939-1676.1990.tb00870.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Antibodies against common gram‐negative core antigens can provide protection against environmental, commensual, and contagious bacteria that cause life‐threatening gram‐negative sepsis/endotoxemia. Cross‐protective immunity may be effective against many common livestock diseases, including neonatal coliform septicemia, coliform mastitis, septic metritis, and severe enteritis. The greatest potential benefit of cross‐protective immunity may be realized in the reduction of ill‐thrift and mortality of neonates. The use of active and passive immunization against core antigens common to gram‐negative bacteria has been successful in human beings, laboratory animals, and livestock. Protection has been observed following challenge with either heterologous endotoxin or unrelated, live, virulent gram‐negative bacteria. (Journal of Veterinary Internal Medicine 1990; 4:17–25) Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [31] Targeting BAM for Novel Therapeutics against Pathogenic Gram-Negative Bacteria
    Cottom, Claire Overly
    Stephenson, Robert
    Wilson, Lindsey
    Noinaj, Nicholas
    ANTIBIOTICS-BASEL, 2023, 12 (04):
  • [32] Novel mechanism of outer membrane targeting of proteins in Gram-negative bacteria
    Ferrandez, Yann
    Condemine, Guy
    MOLECULAR MICROBIOLOGY, 2008, 69 (06) : 1349 - 1357
  • [33] Quorum sensing inhibition: Targeting chemical communication in Gram-negative bacteria
    Persson, T
    Givskov, M
    Nielsen, J
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (26) : 3103 - 3115
  • [34] Polysaccharide-Targeting Lipid Nanoparticles to Kill Gram-Negative Bacteria
    Lai, Xiangfeng
    Chow, Seong Hoong
    Le Brun, Anton P.
    Muir, Benjamin W.
    Bergen, Phillip J.
    White, Jacinta
    Yu, Heidi H.
    Wang, Jiping
    Danne, Jill
    Jiang, Jhih-hang
    Short, Francesca L.
    Han, Mei-Ling
    Strugnell, Richard A.
    Song, Jiangning
    Cameron, Neil R.
    Peleg, Anton Y.
    Li, Jian
    Shen, Hsin-Hui
    SMALL, 2024, 20 (06)
  • [35] MONOTHERAPY OR COMBINATION THERAPY? TARGETING GRAM-NEGATIVE BACTERIA IN PATIENTS WITH SEPSIS
    Welch, Emily
    Micek, Scott T.
    Doherty, Joshua A.
    Reichley, Richard M.
    Kollef, Marin H.
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A157 - A157
  • [36] DEFECTIVE CELLULAR IMMUNITY TO GRAM-NEGATIVE BACTERIA IN CYSTIC-FIBROSIS PATIENTS
    SORENSEN, RU
    STERN, RC
    CHASE, P
    POLMAR, SH
    INFECTION AND IMMUNITY, 1979, 23 (02) : 398 - 402
  • [37] Resistance mechanisms in Gram-negative bacteria
    Lepe, J. A.
    Martinez-Martinez, L.
    MEDICINA INTENSIVA, 2022, 46 (07) : 392 - 402
  • [38] LYSIS OF GRAM-NEGATIVE BACTERIA BY LYSOZYME
    REPASKE, R
    BIOCHIMICA ET BIOPHYSICA ACTA, 1956, 22 (01) : 188 - 191
  • [39] THE LYSOZYME SPECTRUM OF THE GRAM-NEGATIVE BACTERIA
    PETERSON, RG
    HARTSELL, SE
    JOURNAL OF INFECTIOUS DISEASES, 1955, 96 (01): : 75 - 81
  • [40] Oligonucleotide recombination in Gram-negative bacteria
    Swingle, Bryan
    Markel, Eric
    Costantino, Nina
    Bubunenko, Mikhail G.
    Cartinhour, Samuel
    Court, Donald L.
    MOLECULAR MICROBIOLOGY, 2010, 75 (01) : 138 - 148